Abstract: The present invention relates to novel antiobesity and hypocholesterolemic compounds, their derivatives, their analogs, their tautomeric forms, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutically acceptable compositions containing them. More particularly, the present invention relates to novel .beta.-aryl-.alpha.-oxysubstituted alkylcarboxylic acids of the general formula (I), their derivatives, their analogs, their tautomeric forms, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutically acceptable compositions containing them.
Type:
Grant
Filed:
October 26, 1998
Date of Patent:
October 10, 2000
Assignees:
Dr. Reddy's Research Foundation, Reddy-Cheminor, Inc.
Abstract: The present invention relates to novel antidiabetic compounds, their tautomeric forms, their derivatives, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutically acceptable compositions containing them.
Type:
Grant
Filed:
July 14, 1999
Date of Patent:
September 5, 2000
Assignees:
Dr. Reddy's Research Foundation, Reddy-Cheminor Inc.
Abstract: Novel .beta.-aryl-.alpha.-oxysubstituted alkylcarboxylic acids of the formula (I) and compositions containing them. ##STR1## The compounds have hypolipidemic, antihyperglycemic uses.
Type:
Grant
Filed:
January 23, 1998
Date of Patent:
April 25, 2000
Assignees:
Redd's Research Foundation, Reddy-Cheminor, Inc.
Abstract: This invention particularly relates to novel pyridylmethylsulfinyl benzimidazole represented by the general formula (I), its tautomers, its derivatives, its analogs, its stereoisomers, its polymorphs, its pharmaceutically acceptable salts, its pharmaceutically acceptable solvates and pharmaceutical compositions containing them and the use thereof. ##STR1## The present invention also relates to a process for the preparation of the above said novel pyridylmethylsulfinyl benzimidazoles and pharmaceutical compositions containing them.
Type:
Grant
Filed:
March 10, 1998
Date of Patent:
April 18, 2000
Assignees:
Dr. Reddy's Research Foundation, Reddy-Cheminor, Inc.
Abstract: The present invention relates to novel antidiabetic compounds, their tautomeric forms, their derivatives, their analogues, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutically acceptable compositions containing them. This invention particularly relates to novel azolidinediones of the general formula (I), their analogues, their derivatives, their tautomeric forms, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, pharmaceutically acceptable solvates and pharmaceutical compositions containing them.
Type:
Grant
Filed:
August 17, 1998
Date of Patent:
February 29, 2000
Assignees:
Dr. Reddy's Research Foundation, Reddy-Cheminor, Inc.
Abstract: Novel antidiabetic compounds, their tautomeric forms, their derivatives, their analogues, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutically acceptable compositions containing them; methods for preparing the antidiabetic compounds and their uses.
Type:
Grant
Filed:
December 2, 1997
Date of Patent:
January 4, 2000
Assignees:
Dr. Reddy's Research Foundation, Reddy-Cheminor, Inc.
Abstract: The present invention relates to novel antidiabetic compounds, their tautomeric forms, their analogues, their derivatives, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutically acceptable compositions containing them. This invention particularly relates to novel azolidinedione compounds of the general formula (I), and their analogues, their derivatives, their tautomeric forms, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, pharmaceutically acceptable solvates and pharmaceutical compositions containing them.
Type:
Grant
Filed:
December 2, 1997
Date of Patent:
January 4, 2000
Assignees:
Dr. Reddy's Research Foundation, Reddy-Cheminor, Inc.
Abstract: The present invention relates to novel antidiabetic compounds, their tautomeric forms, their derivatives, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutically acceptable compositions containing them. This invention particularly relates to novel azolidinedione derivatives of the general formula (I), and their pharmaceutically acceptable salts, pharmaceutically acceptable solvates and pharmaceutical compositions containing them.
Type:
Grant
Filed:
June 30, 1997
Date of Patent:
November 16, 1999
Assignees:
Dr. Reddy's Research Foundation, Reddy-Cheminor Inc.
Abstract: Novel antidiabetic compounds, their tautomeric forms, their derivatives, their steroisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceuticals acceptable compositions containing them; methods for preparing the antidiabetic compounds and their uses.
Type:
Grant
Filed:
May 5, 1997
Date of Patent:
July 6, 1999
Assignees:
Dr. Reddy's Research Foundation, Reddy-Cheminor, Inc.
Abstract: The present invention relates to novel antidiabetic compounds, their tautomeric forms, their derivatives, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutically acceptable compositions containing them. This invention particularly relates to novel azolidinedione derivatives of the general formula (I), and their pharmaceutically acceptable salts, pharmaceutically acceptable solvates and pharmaceutical compositions containing them.
Type:
Grant
Filed:
May 5, 1997
Date of Patent:
March 30, 1999
Assignees:
Dr. Reddy's Research Foundation, Reddy-Cheminor, Inc.
Abstract: Novel antidiabetic compounds, their tautomeric forms, their derivatives, their steroisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutical acceptable compositions containing them: Methods for preparing the antidiabetic compounds and their uses.
Type:
Grant
Filed:
May 5, 1997
Date of Patent:
March 30, 1999
Assignees:
Reddy's Research Foundation, Reddy-Cheminor, Inc.
Abstract: The present invention relates to novel antidiabetic compounds, their tautomeric forms, their derivatives, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutically acceptable compositions containing them. This invention particularly relates to novel azolidinedione derivatives of the general formula (I), and their pharmaceutically acceptable salts, pharmaceutically acceptable solvates and pharmaceutical compositions containing them.
Type:
Grant
Filed:
December 31, 1996
Date of Patent:
March 23, 1999
Assignees:
Dr. Reddy's Research Foundation, Reddy-Cheminor, Inc.
Abstract: Novel antidiabetic compounds, their tautomeric forms, their derivatives, their steroisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceuticaly acceptable compositions containing them; methods for preparing the antidiabetic compounds and their uses.
Type:
Grant
Filed:
July 26, 1996
Date of Patent:
September 1, 1998
Assignees:
Dr. Reddy's Research Foundation, Reddy-Cheminor, Inc.